Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys

$ARNA, $CHH, $CODX, $NVAX, $PANW

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below is our list for Tuesday, 19 May, as follows:

Arena Pharmaceuticals Inc. (NASDAQ:ARNA) was started with a Buy rating and a 62 price target at Jefferies.

Choice Hotels International Inc. (NASDAQ:CHH) was raised to Buy from Neutral with an 85 price target at Longbow Research.

Co-Diagnostics Inc. (NASDAQ:CODX) was reiterated as Buy and the price target was raised to 35 from 20 at HC Wainwright.

Novavax Inc. (NASDAQ:NVAX) was reiterated as Buy and its price target was raised to 53 from 42 at B Riley FBR.

Palo Alto Networks Inc. (NYSE:PANW) was reiterated as Buy and its price target was raised to 250 from 220 at SunTrust Robinson Humphrey.

Have a healthy day, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.